abstract |
According to the invention, there is provided a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for producing such a compound; and using such a compound in the treatment of a painful condition mediated by epithelial sodium channels (such as asthma, cystic fibrosis or chronic obstructive pulmonary disease). |